Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DB25FWR81
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,552
Award facts
- Contract value 100% obligated
- $19,552.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,552.25 to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300mg dose in 2 pen/ml configuration. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 1, 2025, issued on July 31, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of medications and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company has demonstrated capability to meet federal procurement requirements through competitive award processes, with its DLA contract portfolio encompassing specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. Cosentyx, a biologic immunosuppressant used primarily for autoimmune conditions, represents a specialty pharmaceutical product typical of the specialized healthcare commodities supplied through this prime vendor relationship to support Defense Health Agency and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FWR81?
SPE2DB25FWR81 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 31, 2025.
How much is contract SPE2DB25FWR81 worth?
The government has obligated $19,552 on SPE2DB25FWR81.
Is contract SPE2DB25FWR81 an order under another contract?
Yes. SPE2DB25FWR81 is a delivery order under SPE2DB22D3501, an indefinite delivery contract.
Was contract SPE2DB25FWR81 competed?
The extent of competition for SPE2DB25FWR81 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award